BioWa announces extended licensing to MedImmune
uusjio | October 30, 2007 at 04:56 amby
226 views | 0 Recommendations | 0 comments
"We are pleased to extend our relationship with MedImmune, a world-leading biologics business and the cornerstone to AstraZeneca's plans to establish a major international presence in the research and development of biological therapeutics," said Dr. Masamichi Koike, President and CEO of BioWa.
"With MedImmune's superior expertise in antibody-based drug development, this collaboration complements BioWa's mission to bring about the benefit of POTELLIGENT(R) Technology to patients as quickly as possible."